142 related articles for article (PubMed ID: 36943383)
21. Cost minimization analysis of mainstay treatments in cutaneous lupus erythematous.
Rizvi SK; Chong BF
Dermatol Ther; 2022 Jan; 35(1):e15190. PubMed ID: 34734663
[TBL] [Abstract][Full Text] [Related]
22. Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib.
Joos L; Vetterli F; Jaeger T; Cozzio A; von Kempis J; Rubbert-Roth A
Clin Exp Dermatol; 2022 Apr; 47(4):748-750. PubMed ID: 34747511
[TBL] [Abstract][Full Text] [Related]
23. [Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].
Sticherling M
Z Rheumatol; 2013 Jun; 72(5):429-35. PubMed ID: 23743985
[TBL] [Abstract][Full Text] [Related]
24. Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus.
Penha MÁ; Libório RDS; Miot HA
An Bras Dermatol; 2018 Jun; 93(3):467-469. PubMed ID: 29924233
[No Abstract] [Full Text] [Related]
25. Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients.
Stevens RJ; Andujar C; Edwards CJ; Ames PR; Barwick AR; Khamashta MA; Hughes GR
Br J Rheumatol; 1997 Mar; 36(3):353-9. PubMed ID: 9133968
[TBL] [Abstract][Full Text] [Related]
26. A case of reactive granulomatous dermatitis associated with neonatal lupus erythematosus.
Xing MH; Onajin O; Venkataraman G; Stein SL
J Cutan Pathol; 2023 Sep; 50(9):793-797. PubMed ID: 37311658
[TBL] [Abstract][Full Text] [Related]
27. A case of nodular cutaneous lupus mucinosis.
Terao H; Moroi Y; Urabe K; Koga T; Furue M
J Dermatol; 2003 Apr; 30(4):341-3. PubMed ID: 12707473
[TBL] [Abstract][Full Text] [Related]
28. Update on the management of cutaneous lupus erythematosus.
Callen JP
Br J Dermatol; 2004 Oct; 151(4):731-6. PubMed ID: 15491411
[TBL] [Abstract][Full Text] [Related]
29. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
[No Abstract] [Full Text] [Related]
31. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
Nutan F; Ortega-Loayza AG
J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S64-S68. PubMed ID: 28941497
[TBL] [Abstract][Full Text] [Related]
32. Thalidomide in cutaneous lupus erythematosus.
Pelle MT; Werth VP
Am J Clin Dermatol; 2003; 4(6):379-87. PubMed ID: 12762830
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.
Kishi C; Motegi SI; Yasuda M; Ishikawa O
J Dermatol; 2018 Aug; 45(8):1020-1022. PubMed ID: 30133802
[No Abstract] [Full Text] [Related]
34. Thalidomide: Still an important second-line treatment in refractory cutaneous lupus erythematosus?
Baret I; De Haes P
J Dermatolog Treat; 2015 Apr; 26(2):173-7. PubMed ID: 24731053
[TBL] [Abstract][Full Text] [Related]
35. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
Kuhn A; Aberer E; Bata-Csörgő Z; Caproni M; Dreher A; Frances C; Gläser R; Klötgen HW; Landmann A; Marinovic B; Nyberg F; Olteanu R; Ranki A; Szepietowski JC; Volc-Platzer B
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):389-404. PubMed ID: 27859683
[TBL] [Abstract][Full Text] [Related]
36. Emerging therapies for cutaneous lupus erythematosus.
Borucki R; Werth VP
Cutis; 2020 Jun; 105(6):276-277. PubMed ID: 32716989
[No Abstract] [Full Text] [Related]
37. Lenalidomide for the treatment of resistant discoid lupus erythematosus.
Shah A; Albrecht J; Bonilla-Martinez Z; Okawa J; Rose M; Rosenbach M; Werth VP
Arch Dermatol; 2009 Mar; 145(3):303-6. PubMed ID: 19289762
[TBL] [Abstract][Full Text] [Related]
38. Remission of incapacitating acute cutaneous lupus erythematosus in a patient with systemic lupus erythematosus by B cell-depletive therapy.
Kok MR; Vos K; Bos JD; Tak PP
J Clin Rheumatol; 2010 Oct; 16(7):345. PubMed ID: 20859218
[No Abstract] [Full Text] [Related]
39. Beneficial effect of hydroxychloroquine on cutaneous vasculitis in a Japanese patient with systemic lupus erythematosus.
Kibune N; Shimomura Y; Hasegawa A; Saeki T; Umemori Y; Abe R
J Dermatol; 2017 Apr; 44(4):e52-e53. PubMed ID: 27569899
[No Abstract] [Full Text] [Related]
40. [Systemic therapy of cutaneous lupus erythematosus].
Ochsendorf F
J Dtsch Dermatol Ges; 2004 Mar; 2(3):229-30; author reply 230. PubMed ID: 16281642
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
